Stockreport

Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference

Immuneering Corporation - Class A  (IMRX) 
PDF NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive and help [Read more]